Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
21.22
-0.17 (-0.79%)
Nov 20, 2026, 10:25 AM EST - Market open
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $7.39 billion as of November 20, 2026. It is the 2,562nd most valuable company in the world and the 876th biggest in the United States. Its market cap has increased by 104.15% in one year.
Market Cap
7.39B
Enterprise Value
10.51B
1-Year Change
104.15%
Global Rank
Country Rank
#876 United States
Category
ChartMarket Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has increased from $5.76B to $7.39B, an increase of 28.35%. That is a compound annual growth rate of 2.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 7.39B | 86.65% |
| Dec 31, 2025 | 3.96B | 61.41% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
| Mar 27, 2018 | 5.76B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 16.79B |
| Elanco Animal Health | 12.92B |
| Dr. Reddy's Laboratories | 12.37B |
| Alkermes | 7.64B |
| Kiniksa Pharmaceuticals International, | 7.47B |
| Lantheus Holdings | 6.66B |
| Supernus | 6.03B |
| Liquidia | 5.11B |